| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |